Related Experiment Video
Updated: Dec 1, 2025

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
Pathophysiology of Cardiovascular Complications in COVID-19
Vladimir Petrovic1, Dina Radenkovic2, Goran Radenkovic1
1Department of Histology and Embryology, Faculty of Medicine, University of Nis, Nis, Serbia.
Insights
Patients with cardiovascular disease (CVD) face higher COVID-19 mortality. COVID-19 can cause new heart problems, especially in older adults, necessitating clear clinical protocols for managing these cardiovascular complications.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Patients with pre-existing cardiovascular disease (CVD) exhibit increased severity and mortality from COVID-19.
- COVID-19 is linked to new-onset cardiovascular complications, particularly in older individuals and those with chronic cardiometabolic conditions.
- The SARS-CoV-2 virus can induce both acute cardiac injury and chronic cardiovascular damage.
Purpose of the Study:
- To review the literature on COVID-19 and cardiovascular complications.
- To discuss the pathophysiology and molecular mechanisms underlying these complications.
- To identify potential novel therapeutic targets for cardiovascular complications in COVID-19 patients.
Main Methods:
- Literature review focusing on cardiovascular complications in COVID-19.
- Analysis of molecular pathways including cytokine release syndrome, RAAS dysregulation, plaque destabilization, and coagulation disorders.
- Review of pediatric inflammatory multisystem syndrome associated with COVID-19.
Main Results:
- Cardiovascular disease (CVD) is a major comorbidity in severe COVID-19 cases, often leading to mortality.
- COVID-19 can trigger various cardiovascular issues, including acute injury and chronic damage.
- Pediatric inflammatory multisystem syndrome is a significant cause of cardiovascular complications in children post-COVID-19.
Conclusions:
- Understanding the pathophysiology of COVID-19-related cardiovascular complications is crucial for identifying treatment targets.
- Clear clinical and follow-up protocols are needed for patients with COVID-19 and CVD.
- Identifying and managing risk factors for cardiovascular complications in COVID-19 patients is essential.
Abstract:
Numerous recent studies have shown that patients with underlying cardiovascular disease (CVD) are at increased risk of more severe clinical course as well as mortality of COVID-19. Also, the available data suggests that COVID-19 is related to numerous de novo cardiovascular complications especially in the older population and those with pre-existing chronic cardiometabolic conditions. SARS-CoV-2 virus can cause acute cardiovascular injury, as well as increase the risk of chronic cardiovascular damage. As CVD seem to be the major comorbidity in critically unwell patients with COVID-19 and patients often die of cardiovascular complications, we review the literature and discuss the possible pathophysiology and molecular pathways driving these disease processes: cytokine release syndrome, RAAS system dysregulation, plaque destabilization and coagulation disorders with the aim to identify novel treatment targets. In addition, we review the pediatric population, the major cause of the cardiovascular complications is pediatric inflammatory multisystem syndrome that is believed to be associated with COVID-19 infection. Due to the increasingly recognized CVD damage in COVID-19, there is a need to establish clear clinical and follow-up protocols and to identify and treat possible comorbidities that may be risk factors for the development of cardiovascular complications.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

